Physician

Muhammad Tai, M.D.

According to 2025 Medicare claims, Muhammad Tai, M.D. (NPI: 1134116262) practices medical oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Saratoga, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12065-4154. Tai is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), participating under the MSSP model.

Tai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 765 traditional Medicare patients, billed 128,429 HCPCS/CPT codes, and received $2,010,831 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,024 prescription claims across 163 beneficiaries totaling $3,181,154 in drug costs, led by Calquence (Acalabrutinib Maleate). 2022 DME data shows 35 claims. Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,054,278 to $2,010,831. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,154,094 to $3,181,154. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,014 to $171.